(19)
(11) EP 4 097 099 A1

(12)

(43) Date of publication:
07.12.2022 Bulletin 2022/49

(21) Application number: 21751080.9

(22) Date of filing: 05.02.2021
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61K 31/437(2006.01)
A61K 31/4709(2006.01)
A61K 33/42(2006.01)
A61P 3/04(2006.01)
A61P 9/00(2006.01)
 C07F 9/53(2006.01)
A61K 31/444(2006.01)
A61K 31/4725(2006.01)
A61P 3/10(2006.01)
A61P 3/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 3/04; A61P 3/06; A61P 3/10; A61P 9/00; C07D 471/04; C07F 9/6561; C07F 9/65685; C07F 9/6584; A61K 31/155; A61K 45/06; A61K 38/26; A61K 31/675
 
C-Sets:
  1. A61K 31/155, A61K 2300/00;
  2. A61K 38/26, A61K 2300/00;
  3. A61K 31/675, A61K 2300/00;
(86) International application number:
PCT/CN2021/075488
(87) International publication number:
WO 2021/155841 (12.08.2021 Gazette 2021/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.02.2020 WO PCT/CN2020/074537
14.08.2020 WO PCT/CN2020/109304

(71) Applicant: Gasherbrum Bio, Inc.
San Francisco, California 94121 (US)

(72) Inventors:
  • MENG, Qinghua
    Shanghai 201210 (CN)
  • LIN, Xichen
    Shanghai 201210 (CN)
  • ZHANG, Haizhen
    Shanghai 201210 (CN)
  • XING, Weiqiang
    Shanghai 201210 (CN)
  • LEI, Hui
    Shanghai 201210 (CN)
  • JENNINGS, Andrew
    San Francisco, California 94121 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) HETEROCYCLIC GLP-1 AGONISTS